Background: up to 50% of patients with fever of unknown origin (FUO) remain undiagnosed despite extensive evaluation. In expertise centers, at least 25-63% of these patients are referred after evaluation in another hospital. The diagnostic and therapeutic yields of referral to an expertise center are currently unknown. Aim: To determine the diagnostic and therapeutic yield of referral of patients with fever of unknown origin (FUO) that remain undiagnosed in non-expertise hospitals. Design: Data on workup, outcome, treatment and prognosis were extracted from medical records of all 236 patients referred to the Radboud university medical center's department of internal medicine because of FUO between January 2005 and June 2014. Results: A final diagnosis could be made in 110 of 192 tertiary referred FUO patients. The rate of diagnosis did not differ between patients referred for first opinion or after tertiary referral (68.2 vs. 57.3%, P ¼ 0.234). Over half of undiagnosed tertiary referred patients were treated, and fever resolved in half of these patients. Of 96 undiagnosed patients, two died (2.1)% and in both death was considered unrelated to the febrile disease. Conclusion: The diagnostic rate in patients with FUO does not differ between patients that are tertiary referred and patients that have not been previously evaluated in another hospital. With a total diagnostic value of 57.3% and an additional therapeutic yield of 10.9% in undiagnosed patients, tertiary referral should therefore be considered in patients that remain undiagnosed in a non-expertise center.
Introduction
Although more than 50 years have passed since its first definition, 1 fever of unknown origin (FUO) remains a major diagnostic challenge encountered by physicians in different fields. As medical care has shifted from mainly inpatient-based to outpatient-based care, the original Petersdorf criteria, that included a minimal number of inpatient days, have been replaced by new ones, which include required additional laboratory and microbiologic investigations and imaging instead of the qualitative time criterion (Table 1) . FUO is closely related to long-term unexplained inflammation in the absence of fever (inflammation of unknown origin, IUO), for which causes and workup are the same as for FUO. 2 Over 200 causes of FUO have been described. These can be divided into four major categories: infections, malignancy, noninfectious inflammatory diseases (NIID, which includes vasculitides, autoimmune, autoinflammatory and granulomatous diseases) and miscellaneous causes.
Patients with FUO are seen in all layers of the health care system: general practitioners, medical specialists in community hospitals and medical specialists in university referral centers will all encounter patients with FUO on a regular basis. At least 25-63% of patients in European FUO cohorts are referred to the study center from another hospital. [2] [3] [4] [5] [6] [7] These referrals can be divided into two groups: (i) patients referred for second opinion: in this case patients are referred for a single visit to confirm or reject a (suspected) diagnosis made elsewhere, and (ii) tertiary referred patients, in whom the diagnostic investigation and sometimes treatment are taken over by the new hospital altogether. As patients with FUO are without a diagnosis, we will only use the term tertiary referral here for all patients referred from another hospital. Tertiary referral is associated with increased health care costs, which depend on the medical problem, the complexity of the individual case and possible additional investigations. Tertiary referral may be time consuming for both physician and patients and may lead to delay in initiation of treatment. On the other hand, tertiary referral may lead to a final diagnosis, to the initiation of targeted therapy influencing prognosis and to limiting costs and side effects of unnecessary treatment. Tertiary referrals can be either patient initiated or physician initiated. A recent study on 6791 patient-initiated second opinions of medical records showed that this type of second opinion overall led to a change in diagnosis in 14.8% or treatment in 37.4% of cases, and in 20.9 and 30.7% of cases, respectively, these changes had moderate to major clinical impact. 8 In tertiary referral, the yield may be higher as new investigations will often be performed. Patients in whom no diagnosis can be found may also benefit from tertiary referral as they may better accept their complaints in absence of a diagnosis when they are evaluated by medical specialists in another hospital or by a recognized expert. We studied the diagnostic and therapeutic yield of tertiary referral of patients with FUO to an expertise center.
Materials and methods
The Radboud university medical center (Radboudumc) is a 630-bed university medical center in The Netherlands. The department of internal medicine has functioned as an expertise center on FUO for over 20 years.
Patient selection
All patients with FUO or IUO referred to the internal medicine department between January 2005 and June 2014 were eligible for inclusion in this study. We will refer to both FUO and IUO as FUO in this article, as workup and causes are the same. 2 Patients referred to the internal medicine outpatient department had already been prospectively identified upon referral by two of the investigators (AS and CB), who have been responsible for the triage of all patients referred for these problems during the study period. All patients referred because of FUO/IUO are accepted for evaluation and triage is only used to select consultants with specific expertise. Patients directly referred to the inpatient internal medicine/infectious diseases ward were retrospectively identified by screening of problem lists, encompassing all actual medical problems for admitted patients during grand rounds. All patients with either fever, inflammation, elevated c-reactive protein (CRP), or elevated erythrocyte sedimentation rate (ESR) on their problem lists were possible FUO patients.
In the second step, medical charts of all possible FUO patients were studied by one of the investigators (CM) to select only patients that fulfilled all FUO or IUO criteria (Table 1) . A standard workup flowchart including early PET-CT as previously described 5 was available during the study (Figure 1 ).
Data extraction
Data were extracted from medical records. The final diagnosis was identified and categorized as infection, NIID, malignancy, miscellaneous or no diagnosis. The test directly leading to the final diagnosis was identified. The end of follow up was defined • Chest X-ray, abdominal ultrasound or chest and abdominal CT-scan.
No known immunocomprommised state:
• Neutropenia (leukocyte count <1.0 Â 10 9 /l or granulocyte count <0.5 Â 10 9 /l during at least 1 week within the 3 months before the start of the fever) • Known human immunodeficiency virus (HIV) infection
• Known hypogammaglobulinemia (IgG < 50% of normal value)
• Use of 10 mg prednisone or equivalent dose of steroids during at least 2 weeks in the 3 months before the start of the fever as the last telephone, in-or outpatient contact with the Radboudumc.
All patients that had visited at least one other hospital because of FUO before referral were considered tertiary referred patients, while patients that had not visited any hospitals before were categorized as first opinions. If patients referred by a primary physician had previously visited another hospital because of FUO, they were included in the tertiary referral group. Patients referred by internal consultants were considered primary referral if the main problem treated by the referring consultant was different from fever and patients were referred to the internal medicine department because of FUO.
If any information from the chart was unclear, it was discussed between all four investigators until consensus was reached.
This study was reviewed by the medical ethics committee (METC) Arnhem-Nijmegen (registration number 2014/236) and was exempt from approval according to Dutch law (Wet medisch-wetenschappelijk onderzoek met mensen, WMO), because of its retrospective design and the anonymous storage of data.
Statistical analysis
All continuous data were checked for normality of distribution and homogeneity of variance. Continuous data are represented as mean 6 standard deviation or median (range) and compared using Mann-Whitney U test depending on distribution. Categorical data are represented as number (percentage) unless otherwise specified, and were compared using two-sided Fisher's exact test. A P values <0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS statistics, version 22 for Windows. 
Results

Patient characteristics
A total of 422 possible FUO patients were identified. At first screening, 42 patients were excluded, and another 144 patients did not fulfill all FUO criteria and were subsequently excluded ( Figure 2) .
Patient characteristics are shown in Table 2 . Of all FUO patients, 81.4% were tertiary referred. Of these, 12.0% were referred by a general practitioner, 83.2% by a consultant from another hospital (151 patients from a community and 9 patients from another university hospital) and 4.2% by a consultant from our own hospital. Of all tertiary referred patients, 72.4% were referred by an internist.
Before referral to our hospital, tertiary referred patients had visited a median of one hospital (range 1-7 hospital) and three consultants (range 1-15 consultants) because of FUO. Only 9.4% of tertiary referred patients had not been seen by an internist, while 11.5% had already visited multiple internists. Of these patients, 78.1% had been admitted at least once because of FUO (median number of admission 2, range 1-25 admissions), with a median total duration of 15 days (range 1-174 days).
115 tertiary referred patients (59.9%) underwent at least one 18 F-FDG-PET-CT before referral to the expertise center. Table 3 shows the final diagnoses in the entire group of patients. In 140 patients (59.3%) a cause for FUO was found. NIID were the most common (31.4%).
Diagnosis
The percentage of undiagnosed patients did not significantly differ between patients referred for first opinion and tertiary referred patients (31.8 vs. 42.7%, P ¼ 0.234) ( Table 4 ).
Compared to tertiary referred patients, patients referred for first opinion were significantly more often diagnosed with infections (34.0 vs. 12.0%, P ¼ 0.001), while percentages of NIID, malignancy and miscellaneous causes did not differ between the two groups.
The largest proportion of diagnoses was based on clinical criteria (30.7%), followed by pathology (25.7%) and microbiology (14.3%) results (Figure 3 ). Patients that initially presented with fever lasting <3 weeks that later fulfilled all inclusion criteria for FUO were included from the first day of presentation. Patients referred by primary physician were considered tertiary referrals if they had visited at least one other hospital because of FUO. e Patients referred by an internal consultant were considered primary referrals if the main problem treated by this consultant was not fever.
Diseases diagnosed on high clinical suspicion were recurrent respiratory tract infections in three cases, drug fever in two cases and recurrent infections (a Campylobacter jejuni infection was proven in this patient during the last fever episode), dental infection (fever subsided after removal of all teeth), Crohn's disease (multiple intestinal biopsies showed chronic inflammation without typical signs for Crohn's disease, but fever subsided after treatment), neutrophilic urticaria with systemic inflammation (NUSI), recurrent aspiration (in an obese patient with a dysfunctional gastric band and obstructive sleep apnea syndrome), hydradenitis suppurutiva, idiopathic transverse myelitis and postinfectious benign hyperthermia all in one case.
Workup of FUO patients
The median duration from first presentation to diagnosis was 57 days (range 0-2602 days), without significant difference between patients referred for first opinion and tertiary referred patients (P ¼ 0.171). A median of three outpatient contacts (range 0-41 contacts) were needed before a diagnosis was reached in both groups (P ¼ 0.193). Six patients referred for first opinion (13.6%) and 25 tertiary referred patients (13.0%) were diagnosed without any outpatient contacts: these 31 patients were directly admitted after referral and diagnosed during the index or a subsequent admission without any outpatient contact in between. In the case of first opinion, these patients were referred to the emergency department and admitted or transferred from another ward in our hospital. 161 patients (68.2%) were admitted during the workup. The proportion of admitted patients did not differ between patients referred for first opinion and tertiary referred patients (72.7% vs. 67.2%, P ¼ 0.591).
In the 96 patients without a diagnosis, the number of outpatient visits was significantly higher than in patient with a final diagnosis (median 5 vs. 2 visits, P < 0.001). Undiagnosed patients were admitted less frequently (58.3% vs. 75.0%, P ¼ 0.016).
In 51 patients, a total of 98 pathology studies performed before referral and a total of 133 previous imaging results from 66 individual patients were reviewed during the workup. Ten revisions of pathology led to new findings (10.2%) and these were contributory to the final diagnosis in six cases (6.1%). Revision of imaging revealed new findings in 25 studies (18.8%) and five of these contributed to the final diagnosis (3.8%).
Follow up and survival
The median follow up in the entire cohort was 23 months (range 0-116 months). There were no differences in follow up between patients with and without a final diagnosis (P ¼ 0.108) or between patients referred for first opinion and tertiary referred patients (P ¼ 0.619).
During follow up, 24 patients (10.2%) died, 12 in the first opinion group and 12 in the tertiary referral group (27.3 vs. 6.3%, P < 0.001).
Three patients died before a diagnosis was made. One of them was diagnosed with non-Hodgkin lymphoma on autopsy. So, in the group of 96 patients without a final diagnosis, two patients (2.1%) died. Both patients, aged 81 and 84 years, respectively, died of heart failure, respectively, 38 and 42 months after the first visit to our hospital. The cause of death did not appear to be related to FUO: the first patient died of acute heart failure during rehydration therapy because of newly diagnosed diabetes mellitus. In the second patient autopsy revealed terminal heart failure with recent myocardial infarction without signs of endocarditis.
Management of patients without a diagnosis
Median follow up in the 96 patients without a diagnosis was 20.5 months (range 0-98 months). Eleven patients (11.5%) were followed for less than 1 month, these were all tertiary referred patients. The total duration of follow up was the same for patients referred for first opinion and tertiary referred patients (P ¼ 0.574).
Fifteen undiagnosed tertiary referred patients (18.3%) and three undiagnosed patients referred for first opinion (21.4%) showed spontaneous resolution of fever (P ¼ 0.722).
Five patients referred for first opinion and 42 tertiary referred patients received treatment in absence of a diagnosis: antibiotics in 12 patients (12.5%), NSAIDs/acetaminophen in 15 (15.6%), corticosteroids in 24 (25.0%), anakinra in 19 (19.8%), other immunosuppressants in 6 (6.3%), thalidomide in 2 (2.1%) and other treatment in 27 patients (28.1%). Fifteen patients (15.6%) showed resolution of fever after treatment. Treatment with NSAIDs/acetaminophen had the highest response rate (26.7%).In the 42 patients that became afebrile with or without treatment during follow up, fever subsided after a median duration of 3 months from presentation (range 0-86 months, excluding one patient referred for fist opinion that became afebrile 2 months before first presentation). Patients referred for first opinion had shorter duration of fever from the first visit to the Radboudumc than tertiary referred patients (0.5 vs. 5 months, P ¼ 0.029).
Discussion
This retrospective cohort study shows that in 57.3% of tertiary referred patients with FUO a diagnosis could be made in a university FUO expertise center. In addition, treatment initiated in the expertise center led to resolution of fever in an additional 10.9% of tertiary referred patients in whom no diagnosis could be made. The total positive yield of tertiary referral in patients with FUO is therefore 68.2%. Prognosis of undiagnosed patients was good: mortality was only 2.1% and unrelated to the suspected febrile disease in both cases. Almost half of undiagnosed patients became afebrile with or without treatment. This did not differ between patients referred for first opinion and tertiary referred patients.
The insight in the yield of tertiary referral in patients with FUO is important, as in university and probably also in larger community hospitals, many of these patients will be tertiary referrals, or patients may ask for a tertiary referral themselves when they remain undiagnosed. In our cohort, over 80% of patients were tertiary referred. As before this study the yield of tertiary referral was unknown, referral to a FUO expertise center may have been postponed or even discouraged by the treating physician. However, the total diagnostic and therapeutic yield of 68.2% in this study illustrates that tertiary referral has major advantages in patients with FUO. The diagnostic yield of 57.3% is in fact approximately equal to that of the most recent unselected European cohorts, were 30-50% of patients remained undiagnosed. The only other study that reported the diagnostic yield of tertiary referral in FUO patients is the previous Dutch study by Bleeker-Rovers et al., 5 in which our group was also involved. They found a diagnostic yield of 32% in patients previously evaluated in another hospital. This study reported a significantly higher diagnostic rate in patients referred for first opinion than for tertiary referred patients. We did not find any significant difference in diagnostic yield between these groups. This difference may arise from the fact that the previous Dutch FUO study was a multicenter study, in which 68.8% of first opinions were seen in community hospitals, so it probably included less complex first opinion cases. Other studies have compared the diagnostic yields in patients referred by general practitioners or consultants from another hospital. In European cohorts 17.4-55% of FUO patients are referred by consultants or have been evaluated in another hospital before referral. 3, 4, 6, 7 However, as 12% of tertiary referral in our cohort were referred by general practitioner the type of referral does not directly discriminate between first opinion or tertiary referral. The high diagnostic yield of tertiary referral to our expertise center for FUO could have several explanations: first, our center has over 20 years of experience with FUO/IUO. These patients are seen by a small group of internists, who therefore have high exposure to these patients. As a general rule, patients with FUO rather suffer from an uncommon presentation of a common disease than from an uncommon disease. In approximately 40% of patients in our cohort the final diagnosis was based either on clinical criteria or high clinical suspicion instead of a reproducible golden standard test. To diagnose criterion based diseases, to recognize rare presentations of diseases, or to diagnose rare diseases, pattern recognition is of foremost importance. High exposure to FUO patients leads to higher exposure to rare phenotypes and better pattern recognition. The Radboudumc uses a standardized diagnostic workup for FUO, which has proven high diagnostic yield. 5 ( Figure 1 ) The use of standardized diagnostic methods may improve the diagnostic yield in patients in whom potentially diagnostic clues are absent or misleading. In many patients, pathology results and previous imaging were revised, leading to new findings in 10.2 and 18.8%, respectively. Of all new findings, 20-60% contributed to the final diagnosis, indicating that independent revision of previous pathology results and imaging can have an important role in the workup of FUO and may increase the diagnostic yield of tertiary referral. Another factor that may influence the diagnostic yield of tertiary referral is the fact that many patients with FUO were treated with corticosteroids in absence of a diagnosis before referral. In our protocol (Figure 1 ) all corticosteroids and other anti-inflammatory drugs are stopped before further diagnostic tests are performed, as corticosteroids may mask important potential diagnostic clues. 9, 10 During workup, patients that remained without a diagnosis were admitted less frequently than patients in whom a final diagnosis was made. As patients are only admitted when required by the severity of symptoms or when invasive diagnostic tests are necessary, this might be an indication that patients without a diagnosis show fewer or less severe potential diagnostic clues. When the standard workup in Figure 1 is used, admittance of patients in whom no diagnostic clues are present in the outpatient clinic has no additional value.
In 96 patients no diagnosis was found during a median follow up of 20 months. Only two patients died without a diagnosis. Both died of a FUO unrelated cause remote from the index contact. This is in agreement with the largest study on mortality in FUO. 11 Other Dutch studies have reported mortality rates of 13 and a Serbian study that found a mortality of 66.7%, but included only three undiagnosed patients. 14 In non-European cohorts, mortality in undiagnosed FUO patients is slightly higher than in most European cohorts, ranging from 4 to 12.5%. [15] [16] [17] In tertiary referred patients, fever persisted 10 times longer after referral to our hospital than in first opinions. This may be caused by a more complex pathophysiology of fever in tertiary referred patients and already longer duration of fever before 
Conclusion
This is the largest Dutch cohort study on FUO, 3, 5, 7 one of the largest FUO studies in Europe 2, 4, 6, 9, [11] [12] [13] [14] 18, 19 and the only study to date specifically designed to evaluate the diagnostic yield of tertiary referral in FUO. We found no differences in diagnostic yield between first opinion and tertiary referral, with an overall diagnostic yield of 57.3%. Undiagnosed FUO patients may benefit from treatment, increasing the yield of tertiary referral. With a total diagnostic and therapeutic yield of 68.2%, we show that tertiary referral to an university expertise center should be considered for FUO/IUO patients that remain undiagnosed in another hospital.
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